Management of exacerbations in chronic obstructive pulmonary disease in Primary Care
|
|
|
- Ilene Harrell
- 9 years ago
- Views:
Transcription
1 Management of exacerbations in chronic obstructive pulmonary disease in Primary Care Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with significant morbidity and mortality. Patients with frequent exacerbations have high levels of anxiety and depression, significantly impaired health status and faster disease progression. The updated NICE guideline on managing COPD makes the following recommendations: All patients with COPD still smoking, regardless of age, should be encouraged to stop, and offered help to do so, at every opportunity People with stable COPD who remain breathless or have exacerbations despite using short-acting bronchodilators as required should be offered either a long-acting beta-2 agonist (LABA) or long-acting antimuscarinic as maintenance therapy; or (if FEV 1 is below 50% of predicted) either a LABA plus an inhaled corticosteroid in a combination inhaler or a LABA plus long-acting antimuscarinic People with COPD who remain breathless or have exacerbations despite taking a LABA plus inhaled corticosteroid, should be offered long-acting antimuscarinic inaddition, irrespective of their FEV 1 Pulmonary rehabilitation should be available to all appropriate patients with COPD, including those who have had a recent hospitalisation for an acute exacerbation A 2007 systematic review [1] of 13 trials (1557 patients) reported that most patients with COPD exacerbations, who do not need hospital admission, may not benefit from immediate antibiotic treatment. The most prudent choice for these patients might be to withhold antibiotics at first while first line management should include bronchodilators, systemic corticosteroids, patient instruction to use medication correctly as well as follow-up visits. If patients do not recover or show further worsening of health status, antibiotics might still be considered after 3-5 days of first line treatment. Further to this, antibiotic choice has also been investigated and it has been found that amoxicillin was non-inferior to co-amoxiclav in treating patients with exacerbation of COPD in a 2009 paper [3]. Please see treatment flow diagram on how to manage patients with exacerbation of COPD.
2 Patient presents with signs of exacerbation of COPD Assess to decide whether patient needs admission or can be treated in primary care (see appendix 1) Severe exacerbation Treat in Primary Care Admit to hospital Give prednisolone* 30mg daily for 7 days days Consider infective exacerbation and if antibiotics are deemed necessary then prescribe according to guidelines after assessment. Ensure documentation in patients notes to allow a clear audit trail. Consider review after 3 days Consider starting antibiotics after assessment 1 st Line: Amoxicillin 1g TDS for 3 days or 500mg TDS for 5 days Partial Improvement in patients condition Yes Continue with prednisolone and complete 7days of treatment 2 nd Line: Doxycycline 200mg stat then 100mg OD for a total of 5 days 3 rd Line: Clarithromycin 500mg BD for 5 days No 1. Consider adding in an antibiotic as per local guidelines 2. Consider admission Review after completion of treatment. If patient has improved then give advice on how to manage condition. If not improved or worse at any stage, please reassess and consider admission. *If more than 4 courses of prednisolone have been prescribed in a year, consider osteoporosis prophylaxis
3 References 1. Puhan MA, Vollenweider D, Latshang T, Steurer J and Steurer-Stey C. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res. 2007; 8(1): Wilson R. Short course of antibiotic treatment in acute exacerbations of COPD. Thorax 2008;63: Llor C, Hernández S, Ribas A, Álvarez C, Cots JM, Bayona C, González I, Miravitlles M. Efficacy of amoxicillin versus amoxicillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care. Int J COPD 2009; 4: NICE clinical guidance 101. Chronic obstructive pulmonary disease management of chronic obstructive pulmonary disease in adults in primary care and secondary care. June Drug and Theraeutics Bulletin. Preventing exacerbations in chronic obstructive pulmonary disease. BMJ 2011; 342:c Patient information leaflet. Getting through the winter with a bad chest. Provided by Dr Richard Bircher, Lockside Medical Centre uired_pneumonia/admission_and_referral#
4 Appendix 1 Factors to consider when deciding where to manage exacerbations Factor Treat at home? Treat in hospital? Able to cope at home Yes No Breathlessness Mild Severe General condition Good Poor/deteriorating Level of activity Good Poor/confined to bed Cyanosis No Yes Worsening peripheral oedema No Yes Level of consciousness Normal Impaired Already receiving LTOT No Yes Social circumstances Good Living alone/not coping Acute confusion No Yes Rapid rate on onset No Yes Significant comorbidity (particularly cardiac No Yes disease and insulin-dependent diabetes) SaO 2 <90% No Yes Changes on chest X-ray No Present Arterial ph level 7.35 <7.35 Arterial PaO 2 7kPa < 7 kpa (taken from NICE clinical guidance 101)
5 What is CRB-65 and how do I calculate it? Assess the CRB-65 score for all people diagnosed with pneumonia. One point is awarded for each of the following features: Confusion recent Respiratory rate of 30 breaths/min or greater Blood pressure systolic of 90 mmhg or less or diastolic of 60 mmhg or less 65 years old or older For people with a CRB-65 score of 3 or more, arrange urgent admission to hospital. For people with a CRB-65 score of 2, arrange same-day assessment in secondary care. Secondary care options include short-stay inpatient treatment or hospitalsupervised outpatient treatment. For people with a CRB-65 score of 1, consider arranging same-day assessment in secondary care. For people with a CRB-65 score of 0, treatment at home is usually appropriate, depending on clinical judgement (for example the stability of any comorbid illness) and available social support.
6 Getting through the winter with a bad chest Medical advice on how deal with illnesses which effect your chest over the winter months Lockside Medical Centre 85 Huddersfield Road Tips on keeping well As we all know there are many infections, coughs and colds, which go around in the winter months. Certain people with bad chests, especially those with a condition called chronic obstructive pulmonary disease find it difficult to fight off colds and they can soon become a serious chest infection. We feel you are such a patient and we would like to do our best to keep you as well as possible this winter. Though, we can t stop you from catching the coughs and colds that go around, there are some important things which can be done to greatly reduce the chances of a simple winter bug becoming a serious chest infection. have an influenza immunisation have a second immunisation called the pneumovax, this protects you against the commonest bacteria to cause pneumonia. (You need only one of these immunisations in your life) Stop smoking take steps to prevent a serious infection developing as soon as possible. Follow the Winter Chest Plan. (see next page) The winter chest plan You have probably lived with your bad chest for many years and can judge when it is becoming worse. Start steroid tablet treatment if you are unwell with your chest and you are: 1. More short of breath than usual 2. Coughing up more phlegm than normal And start antibiotics tablets if 3. The colour of your phlegm has turned to green or brown Also please: Increase the use of your reliever inhaler (the blue one) Phone the surgery to let us know you are unwell If you are feeling better after three days on your antibiotics there is no need to finish the complete 5 day course. For most people we would not usually recommend early use of antibiotics for winter chest problems. However, you have a chest problem which makes you more at risk of serious infection. Please keep the enclosed prescription safe, and use it if you get unwell. Please do not get the tablets unless you feel you need them.
NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
Exploring the Chronic Obstructive Pulmonary Disease (COPD) Clinical Pathway. Health Quality Ontario s integrated episode of care for COPD
Exploring the Chronic Obstructive Pulmonary Disease (COPD) Clinical Pathway Health Quality Ontario s integrated episode of care for COPD Dr. Charlie Chan Health Quality Ontario Expert Panel Co-Chair May/June
PLAN OF ACTION FOR. Physician Name Signature License Date
PLAN OF ACTION FOR Patient s copy (patient s name) I Feel Well Lignes I feel short directrices of breath: I cough up sputum daily. No Yes, colour: I cough regularly. No Yes I Feel Worse I have changes
COPD Prescribing Guidelines
South Staffordshire Area Prescribing Group COPD Prescribing Guidelines Inhaler choices in this guideline are different from previous versions produced by the APG. It is not expected patients controlled
Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD
Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD This document describes the standard for clinical assessment, prescription, optimal management and follow-up of patients receiving domiciliary
Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD)
Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD) Patients with COPD take a wide variety of medicines to manage their symptoms these include: Inhaled Short Acting Bronchodilators
Prevention of Acute COPD exacerbations
December 3, 2015 Prevention of Acute COPD exacerbations George Pyrgos MD 1 Disclosures No funding received for this presentation I have previously conducted clinical trials with Boehringer Ingelheim. Principal
Chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways
James F. Kravec, M.D., F.A.C.P
James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice
COPD and Asthma Differential Diagnosis
COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive
Pneumonia. Pneumonia is an infection that makes the tiny air sacs in your lungs inflamed (swollen and sore). They then fill with liquid.
Pneumonia Pneumonia is an infection that makes the tiny air sacs in your lungs inflamed (swollen and sore). They then fill with liquid. People with mild (not so bad) pneumonia can usually be treated at
Bronchodilators in COPD
TSANZSRS Gold Coast 2015 Can average outcomes in COPD clinical trials guide treatment strategies? Long live the FEV1? Christine McDonald Dept of Respiratory and Sleep Medicine Austin Health Institute for
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
COPD - Education for Patients and Carers Integrated Care Pathway
Patient NHS COPD - Education for Patients and Carers Integrated Care Pathway Date ICP completed:. Is the patient following another Integrated Care Pathway[s].. / If yes, record which other Integrated Care
Before prescribing for COPD management, the patient should have had appropriate assessment, including spirometry, as per NICE guidelines.
Formulary Guidance for Management of COPD patients Before prescribing for COPD management, the patient should have had appropriate assessment, including spirometry, as per NICE guidelines. For inhaler
Irish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy
31 st Irish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy 1 Introduction Chronic obstructive pulmonary disease (COPD) is an important disease for patients, the health
Pathway for Diagnosing COPD
Pathway for Diagnosing Visit 1 Registry Clients at Risk Patient presents with symptoms suggestive of Exertional breathlessness Chronic cough Regular sputum production Frequent bronchitis ; wheeze Occupational
Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis What is Idiopathic Pulmonary Fibrosis? Idiopathic pulmonary fibrosis (IPF) is a condition that causes persistent and progressive scarring of the tiny air sacs (alveoli) in
National Learning Objectives for COPD Educators
National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the
Pulmonary Rehabilitation in Newark and Sherwood
Pulmonary Rehabilitation in Newark and Sherwood With exception of smoking cessation pulmonary rehabilitation is the single most effective intervention for any patient with COPD. A Cochrane review published
On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
Better Breathing with COPD
Better Breathing with COPD People with Chronic Obstructive Pulmonary Disease (COPD) often benefit from learning different breathing techniques. Pursed Lip Breathing Pursed Lip Breathing (PLB) can be very
RES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP
RES/006/APR16/AR Speaker : Dr. Pither Sandy Tulak SpP Definition of Asthma (GINA 2015) Asthma is a common and potentially serious chronic disease that imposes a substantial burden on patients, their families
Community health care services Alternatives to acute admission & Facilitated discharge options. Directory
Community health care services Alternatives to acute admission & Facilitated discharge options Directory Introduction The purpose of this directory is to provide primary and secondary health and social
written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd
written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are two major diseases included in
The patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.
Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should
COPD It Can Take Your Breath Away www.patientedu.org
written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are 2 major diseases included in COPD:
3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients
Faculty Disclosures COPD Disease Management Tackling the Transition Dr. Cappelluti has no actual or potential conflicts of interest associated with this presentation. Jane Reardon has no actual or potential
CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease
CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts
Asthma and COPD Awareness
Asthma and COPD Awareness Molina Breathe with Ease sm and Chronic Obstructive Pulmonary Disease Molina Healthcare of Michigan Fall 2012 Importance of Controller Medicines Asthma is a disease that causes
COPD RESOURCE PACK SECTION 11. Fife Integrated COPD Care Pathways
COPD RESOURCE PCK SECTION 11 Fife Integrated COPD Care Pathways In this section: 1. COPD Guidance treatment at each stage of the disease 2. Overview of Respiratory (COPD) Integrated Pathway 3. Chronic
Sandwell Community Respiratory Service
Contents Page Community Respiratory Service 2 Service times and locations 3 Oxygen Service 4 Pulmonary Rehabilitation 5 Maintenance Programme 6 Occupational Therapy 7 Dietary support and advice 7 Weatherwise
Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma
Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma Important Complete asthma control needs to be achieved for at least 12 weeks before attempting
WHEN COPD* SYMPTOMS GET WORSE
WHEN COPD* SYMPTOMS GET WORSE *Includes chronic bronchitis, emphysema, or both. Boehringer Ingelheim Pharmaceuticals, Inc. has no ownership interest in any other organization that advertises or markets
COPD MANAGEMENT PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines f the collabative management of patients with a diagnosis of chronic obstructive pulmonary disease (COPD) who are not adequately controlled and to define the roles and
Pneumonia Education and Discharge Instructions
Pneumonia Education and Discharge Instructions Pneumonia Education and Discharge Instructions Definition: Pneumonia is an infection of the lungs. Many different organisms can cause it, including bacteria,
medicineupdate to find out more about this medicine
medicineupdate Asking the right questions about new medicines Seretide for chronic obstructive pulmonary disease What this medicine is 1 What this medicine treats 2 Other medicines available for this condition
Your Go-to COPD Guide
Your Go-to COPD Guide Learning how to live with chronic obstructive pulmonary disease (COPD) Inside, you ll learn: COPD facts COPD symptoms and triggers How to talk with your doctor Different treatment
PCOM Letterhead [Substitute same from participating institution and, of course, change Department, PI, and Co-Investigators]
PCOM Letterhead [Substitute same from participating institution and, of course, change Department, PI, and Co-Investigators] Department of Neuroscience, Physiology and Pharmacology 215-871-6880 PATIENT
Table 1 Performance Measures. Quality Monitoring P4P Yr1 Yr2 Yr3. Specification Source. # Category Performance Measure
Table 1 Performance Measures # Category Performance Measure 1 Behavioral Health Risk Assessment and Follow-up 1) Behavioral Screening/ Assessment within 60 days of enrollment New Enrollees who completed
2010 QARR QUICK REFERENCE GUIDE Adults
2010 QARR QUICK REFERENCE GUIDE Adults ADULT MEASURES (19 through 64 years) GUIDELINE HEDIS COMPLIANT CPT/ICD9 CODES DOCUMENTATION TIPS Well Care Access to Ambulatory Care Ensure a preventive or other
Chronic Obstructive Pulmonary Disease
Page 1 of 10 View this article online at: patient.info/health/chronic-obstructive-pulmonary-disease-leaflet Chronic Obstructive Pulmonary Disease Chronic obstructive pulmonary disease (COPD) is an umbrella
Emphysema. Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide.
Emphysema Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide. Emphysema involves damage to the air sacs in the lungs. This
IN-HOME QUALITY IMPROVEMENT. BEST PRACTICE: DISEASE MANAGEMENT Chronic Obstructive Pulmonary Disease NURSE TRACK
IN-HOME QUALITY IMPROVEMENT BEST PRACTICE: DISEASE MANAGEMENT Chronic Obstructive Pulmonary Disease NURSE TRACK Best Practice Intervention Packages were designed for use by any In-Home Provider Agency
The Problem with Asthma. Ruth McArthur, Practice Nurse/Trainer
The Problem with Asthma Ruth McArthur, Practice Nurse/Trainer Getting the diagnosis right! Asthma or COPD? History taking is key Both are inflammatory conditions with different mechanisms & mediators Diagnostic
Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC
Documenting & Coding Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Sr. Provider Training & Development Consultant Professional Profile David Brigner currently performs
Department of Surgery
What is emphysema? 2004 Regents of the University of Michigan Emphysema is a chronic disease of the lungs characterized by thinning and overexpansion of the lung-like blisters (bullae) in the lung tissue.
MEASURING CARE QUALITY
MEASURING CARE QUALITY Region November 2015 For Clinical Effectiveness of Care Measures of Performance From: Healthcare Effectiveness Data and Information Set (HEDIS ) HEDIS is a set of standardized performance
COPD. Information brochure for chronic obstructive pulmonary disease.
COPD Information brochure for chronic obstructive pulmonary disease. CONTENTS What does COPD mean?...04 What are the symptoms of COPD?...06 What causes COPD?...09 Treating COPD...10 Valve therapy in COPD...12
The flu vaccination WINTER 2016/17. Who should have it and why. Flu mmunisation 2016/17
The flu vaccination WINTER 2016/17 Who should have it and why Flu mmunisation 2016/17 The flu vaccination 1 Winter 2016/17 Helping to protect everyone, every winter This leaflet explains how you can help
Person Centered Care: Walk the Talk
Person Centered Care: Walk the Talk Integration of Nurse Practitioner (NP) Role into Extendicare Michener Hill Long Term Care (LTC) Presented by: Sandi Engi MN, NP Michener Hill Extendicare November 25
HEdis Code Quick Reference Guide Disease Management Services
HEdis Code Quick Reference Guide Disease Management Services Respiratory Conditions Appropriate Testing for Children With Pharyngitis (ages 2-18) [Commercial, Medicaid] Appropriate Treatment (no antibiotic)
SUMMARY OF CHANGES TO QOF 2015/16 - ENGLAND CLINICAL
SUMMARY OF CHANGES TO QOF 2015/1 - ENGLAND KEY No change Retired/replaced Wording and/or change Point or threshold change Indicator ID change 14/15 QOF ID 15/1 QOF ID NICE ID Indicator wording Changes
An Overview of Asthma - Diagnosis and Treatment
An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,
Objectives COPD. Chronic Obstructive Pulmonary Disease (COPD) 4/19/2011
Objectives Discuss assessment findings and treatment for: Chronic Obstructive Pulmonary Disease Bronchitis Emphysema Asthma Anaphylaxis Other respiratory issues Provide some definitions Chronic Obstructive
Southwark Clinical Commissioning Group Lambeth Clinical Commissioning Group
Getting the Vision Right: A multi-disciplinary approach to providing integrated care for respiratory patients Dr Noel Baxter, GP NHS Southwark CCG Dr Irem Patel, Integrated Consultant Respiratory Physician
Achieving Quality and Value in Chronic Care Management
The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of
Sponsor Novartis Pharmaceuticals
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study
Reducing COPD Readmissions and Implications for Pulmonary Rehab. Janie Knipper, APN, MA, AE-C, FAACVPR [email protected]
Reducing COPD Readmissions and Implications for Pulmonary Rehab Janie Knipper, APN, MA, AE-C, FAACVPR [email protected] Statement of Disclosure I have no disclosures. The opinions expressed are my
Pulmonary Diseases. Lung Disease: Pathophysiology, Medical and Exercise Programming. Overview of Pathophysiology
Lung Disease: Pathophysiology, Medical and Exercise Programming Overview of Pathophysiology Ventilatory Impairments Increased airway resistance Reduced compliance Increased work of breathing Ventilatory
Chronic Obstructive Pulmonary Disease Patient Guidebook
Chronic Obstructive Pulmonary Disease Patient Guidebook The Respiratory System The respiratory system consists of the lungs and air passages. The lungs are the part of the body where gases are exchanged
Chronic obstructive pulmonary disease
12 Chronic obstructive pulmonary disease Anna Murphy Case study and questions Day 1 Mr LT, a 68-year-old man, attended his general practitioner s (GP s) surgery for a routine check-up. He had been diagnosed
Lung cancer (non-small-cell)
Patient information from the BMJ Group Lung cancer (non-small-cell) It can be devastating to find out that you or someone close to you has lung cancer. You will have to make some important decisions about
A Detailed Data Set From the Year 2011
2012 HEDIS 2012 A Detailed Data Set From the Year 2011 Commercial Product We are pleased to present the AvMed HEDIS 2012 Report, a detailed data set designed to give employers and consumers an objective
Hospital-at-Home Programs for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): An Evidence-Based Analysis
Hospital-at-Home Programs for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): An Evidence-Based Analysis BR McCurdy March 2012 Ontario Health Technology Assessment Series;
These factors increase your chance of developing emphysema. Tell your doctor if you have any of these risk factors:
Emphysema Pronounced: em-fiss-see-mah by Debra Wood, RN En Español (Spanish Version) Definition Emphysema is a chronic obstructive disease of the lungs. The lungs contain millions of tiny air sacs called
Chronic Obstructive Pulmonary Disease (COPD) Programme
Integrated Care Pathway Chronic Obstructive Pulmonary Disease (COPD) Programme Patient Handbook Contents Preface... 1 What is COPD?... 3 What causes COPD?... 4 - Smoking... 4 - Air pollution... 4 - The
Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis
Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly
Respiratory failure and Oxygen Therapy
Respiratory failure and Oxygen Therapy A patient with Hb 15 G % will carry 3X more O2 in his blood than someone with Hb 5G % Give Controlled O2 treatment in acute pulmonary oedema to avoid CO2 retention
Complete coverage. Unbeatable value.
Quest Travel Insurance Complete coverage. Unbeatable value. Quest with confidence, anytime, anywhere! Quest protects you when nothing else can, with: Future stability coverage: Stable now? Not sure you
Electronic patient diaries in clinical research
Topics Electronic diaries in Clinical Trials Electronic diaries versus Paper Electronic patient diaries in clinical research Case Study: Novel detection of exacerbations of COPD with patient reported outcome
Co-morbiditeit associeert met respiratoire aandoeningen louter omwille van de leeftijd. COPD patiënten hebben veel meer kans op longkanker dan rokers
Academisch centrum huisartsgeneeskunde Pneumologie Juni 2012 Prof W Janssens Co-morbiditeit associeert met respiratoire aandoeningen louter omwille van de leeftijd. COPD patiënten hebben veel meer kans
SWINE FLU: FROM CONTAINMENT TO TREATMENT
SWINE FLU: FROM CONTAINMENT TO TREATMENT SWINE FLU: FROM CONTAINMENT TO TREATMENT INTRODUCTION As Swine Flu spreads and more people start to catch it, it makes sense to move from intensive efforts to contain
Service delivery interventions
Service delivery interventions S A S H A S H E P P E R D D E P A R T M E N T O F P U B L I C H E A L T H, U N I V E R S I T Y O F O X F O R D CO- C O O R D I N A T I N G E D I T O R C O C H R A N E E P
Summary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor)
EMA/662624/2015 Summary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor) This is a summary of the risk management plan (RMP) for Orkambi, which details the measures to be taken
RT AS PROJECT MANAGER:
RT AS PROJECT MANAGER: IMPROVING CARE TRANSITIONS DECREASES UNPLANNED READMISSIONS TAMMY JARNAGIN, BHS, RRT DIRECTOR CARDIOPULMONARY SERVICES, NEURODIAGNOSTICS, HOME MEDICAL EQUIPMENT Objectives Recognize
Exploratory data: COPD and blood eosinophils. David Price: 9.23-9.35am
Exploratory data: COPD and blood eosinophils David Price: 9.23-9.35am Blood Eosinophilia in COPD The reliability and utility of blood eosinophils as a marker of disease burden, healthcare resource utilisation
Adult Home Oxygen Therapy. Purpose To provide guidance on the requirements for and procedures relating to domiciliary oxygen therapy.
Contents Purpose... 1 Scope/Audience... 1 Categories for Home Oxygen Therapy... 2 Assessment for Home Oxygen Therapy... 3 Investigations... 3 Requests for home oxygen... 3 Provision of Home Oxygen... 4
NHS outcomes framework and CCG outcomes indicators: Data availability table
NHS outcomes framework and CCG outcomes indicators: Data availability table December 2012 NHS OF objectives Preventing people from dying prematurely DOMAIN 1: preventing people from dying prematurely Potential
Medicines Use Review Supporting Information for Asthma Patients
Medicines Use Review Supporting Information for Asthma Patients What is asthma? Asthma is a chronic inflammatory disorder of the airways. The inflammation causes an associated increase in airway hyper-responsiveness,
Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version)
Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version) Care Setting ACUTE Activity Confirmation of COPD diagnoses: If time and the patient s condition
Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
Mahidol University Journal of Pharmaceutical Sciences 008; 35(14): 81. Original Article Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
Connection with other policy areas and (How does it fit/support wider early years work and partnerships)
Illness such as gastroenteritis and upper respiratory tract infections, along with injuries caused by accidents in the home, are the leading causes of attendances at Accident & Emergency and hospitalisation
Ohio Health Homes Learning Community Meeting. Overview of Health Homes Measures
Ohio Health Homes Learning Community Meeting Overview of Health Homes Measures Tuesday, March 5, 2013 Presenter: Amber Saldivar, MHSM Associate Director, Informatics Analysis Health Services Advisory Group,
11/2/2015 Domain: Care Coordination / Patient Safety
11/2/2015 Domain: Care Coordination / Patient Safety 2014 CT Commercial Medicaid Compared to 2012 all LOB Medicaid Quality Compass Benchmarks 2 3 4 5 6 7 8 9 10 Documentation of Current Medications in
Intelligent Monitoring Report. Greenford Avenue Family Health Practice 322 Greenford Avenue London W7 3AH
Greenford Avenue Family Health Practice 322 Greenford Avenue London W7 3AH Intelligent Monitoring (IM) Report GP IM is an initial list of 37 indicators that currently cover three of our five key questions
CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN CANCER PATIENTS 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN CANCER PATIENTS 1. Aim/Purpose of this Guideline 1.1. Systemic cancer treatments and immunological therapies can suppress the ability of the bone
The Annual Direct Care of Asthma
The Annual Direct Care of Asthma The annual direct health care cost of asthma in the United States is approximately $11.5 billion; indirect costs (e.g. lost productivity) add another $4.6 billion for a
Tuberculosis: FAQs. What is the difference between latent TB infection and TB disease?
Tuberculosis: FAQs What is TB disease? Tuberculosis (TB) is a disease caused by bacteria (germs) that are spread from person to person through the air. TB usually affects the lungs, but it can also affect
Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care
Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care Charley P. Starnes, RRT, RCP Clinical Respiratory Specialist- COPD Education Important Milestones July 2011-
